Stress Recovery: To recover from periods of high stress or burnout
I also have a lot of patients who have not lost a significant amount of weight on GLP1 agonists or tirzepatide, so genetics also play a role (and definitely lifestyle which is the most important issue we need to address- talk to patients to make changes for the entire family).the patients who have not lost a significant amount of weight may actually be a good cohort to look at for CV benefits- they usually have good glycemic control on these drugs and that of course contributes to decreased inflammatory markers etc so it will still be difficult to pin CV benefits of GLP1 agonists independent of weight loss and glycemic control
semaglutide in Chinese subjects with T2D have been demonstrated in a phase 3a clinical trial (SUSTAIN CHINA MRCT, ClinicalTrials.gov identifier: NCT03061214)
Theres one in particular that has a lot of buzz surrounding it right now: glutathione
2.2.5 Gut microbiota-based therapeutic interventions 2.2.5.1 Probiotics The results of human clinical trials (see Table 5) suggest that probiotics may be beneficial as a supportive therapy for PD
However, compared with the intensive mechanistic studies of carnitine in mammals, the majority of the studies of carnitine in fish have only focused on the effects of carnitine on the fishs growth and body composition, whereas studies on the systemic regulation of nutritional metabolism by carnitine in fish, and the underlying mechanisms, are lacking
.webp)
